immunohistochemical
In 2017, the Union for International Cancer Control immunohistochemical (IHC) marker p16 as a surrogate for HPV infection to separate oropharyngeal cancer (OPC) into p16-positive and p16-negative OPC due to differences tumor characteristics and treatment results.
In 2017, the Union for International Cancer Control immunohistochemical ( IHC ) marker p16 as a surrogate for HPV infection to separate oropharyngeal cancer ( OPC ) into p16-positive and p16-negative OPC due to differences tumor characteristics and treatment results .